Connect with us

Health

Key biomarker for inflammation and COVID-19 risk – Medical Xpress

Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage…

Published

on

Article feature image

Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
In a new paper in International Journal of Infectious Diseases, medical experts in Italy and Australia examined levels of a chemical called serum amyloid A (SAA), a protein synthesized in the liver which can spike up to 1,000-fold within the first 24-48 hours of an infection.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Mum describes heartache after baby’s death at 12-days-old after sensing something was off – nation.lk – The Nation Newspaper
Article feature image
Endometriosis and breast cancer screening set for funding boost in federal budget – ABC News